TrialArthritis and rheumatism2012

Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.

Cailin H Sibley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.